Physician profile
Robert S Lee
NPI 1861684201
$7,781.71
in general payments reported to CMS, 2019-2025
45 companies · $885 in 2025
The $885 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,559 · 2020: $826 · 2021: $1,251 · 2022: $965 · 2023: $1,192 · 2024: $1,103 · 2025: $885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,180.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,528.11 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,124.95 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $867.36 | 2019-2024 | Xarelto |
| Pfizer INC. | $481.83 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $456.47 | 2021-2025 | Verquvo, Capvaxive |
| Amgen INC. | $454.39 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $252.22 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $231.09 | 2022-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $199.51 | 2022-2024 | Camzyos, Eliquis |
| Abiomed | $172.76 | 2024-2025 | Impella |
| Sanofi-Aventis U.S. LLC | $159.19 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $142.48 | 2019-2024 | Wainua |
| Medtronic Vascular, INC. | $141.23 | 2019 | |
| Amarin Pharma, INC. | $131.44 | 2019-2021 | |
| Irhythm Technologies, INC. | $130.15 | 2020-2024 | Zio Monitor, Zio Xt Patch |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.